Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118846 · ClinicalTrials.gov registry record · Phase 2
Women's Isoflavone Soy Health (WISH) Trial
A Phase 2 study, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 2
- Development phase
- 350
- Enrollment target
NCT00118846 is a Phase 2 study that has completed, run by University of Southern California. The registered enrollment target is 350 participants.
The verdict
NCT00118846, a Phase 2 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 350 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether soy supplementation can reduce hardening of the arteries and cognitive decline in postmenopausal women.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT 25 gm soy protein supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2004-04-12 |
| Est. Completion | 2009-03-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00118846
The ClinicalTrials.gov registry entry for NCT00118846 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00118846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00118846 about?
NCT00118846 is a clinical study titled "Women's Isoflavone Soy Health (WISH) Trial". The purpose of this study is to determine whether soy supplementation can reduce hardening of the arteries and cognitive decline in postmenopausal women.
What is the current status of trial NCT00118846?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 350 participants. The study started on 2004-04-12. Estimated completion is 2009-03-19.
What interventions are being tested in trial NCT00118846?
The interventions under investigation include: Placebo (OTHER), 25 gm soy protein supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00118846?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.